$Lantern Pharma (LTRN.US)$ 10% Shareholder Fletcher Aaron G.L. sold 30,000 shares of common stock on May 23, 24, 2024 at an average price of $6.3 for a total value of $189.1K.
This transaction involves other related parties: BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP and BIOS Advisors GP, LLC.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.